May be worth further exploring cannabinoids as potential cancer treatment, say researchers ... Oct 16
In 2018, the FDA approved LORBRENA for the treatment of patients with ALK-positive metastatic NSCLC whose disease has progressed on crizotinib and at least ... Mar 05
Breast cancer was the leading cause of cancer death among women at 15.5%. ... Feb 05
Skinopathy, a new Canadian medical technology start-up, is developing Artificial Intelligence technology to help fight the scourge of skin cancer.... Dec 09
Gavreto is used in treatment of adults with metastatic RET fusion-positive non-small cell lung cancer... Sep 08
Now a safe and cheap way for determining lungs cancer ... Sep 07
After Japan, EU approves AstraZeneca Imfinzi , along with chemotherapy it could treat small cell lung cancer... Sep 02
Imfinzi gets approval in Japan currently FDA has issued it Priority Review status for lungs and bladder cancer treatment... Aug 21
Small cell lungs cancer could be now treated with Zepzeleca... Jun 17
Retevmo is a selective RET kinase inhibitor. Retevmo may affect both tumor cells and healthy cells, which can result in side effects. Retevmo is an ... May 09
And risk similar to that of smokers without chronic lung disease, findings indicate ... Apr 08
AstraZeneca comes up with ground breaking data on lungs cancer... Mar 02
-Advertisements-
Wednesday, May 15, 2024
.jpeg)
